Delayed-onset serum sickness due to rituximab in pemphigus vulgaris
Main Author: | Ajay Deshpande |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Drugs in Dermatology |
Online Access: | http://www.ijdd.in/article.asp?issn=2455-3972;year=2019;volume=5;issue=1;spage=54;epage=57;aulast=Deshpande |
Similar Items
-
Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
by: Mohamad Y. Khatib, et al.
Published: (2021-02-01) -
Sorafenib-induced pemphigus vulgaris
by: Ajay Deshpande
Published: (2016-01-01) -
Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
by: Sharon Baum, et al.
Published: (2020-10-01) -
Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01) -
Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)